| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 164,3 k € | +2.8% | 159,7 k € | -3.4% | 165,3 k € | +1.3% | 163,2 k € | ||||||||||||||||
| Gross margin | 142,3 k € | +37.4% | 103,6 k € | +11.7% | 92,8 k € | -36.6% | 146,2 k € | +17.2% | 124,8 k € | +34.8% | 92,6 k € | +30.8% | 70,8 k € | +29.7% | 54,6 k € | +0.9% | 54,1 k € | -2.4% | 55,4 k € | +2781.6% | -2,1 k € | -103.9% | 52,7 k € | -11.9% | 59,8 k € | +7.8% | 55,4 k € | +46.5% | 37,8 k € | +94.2% | 19,5 k € | -60.8% | 49,7 k € | +1.8% | 48,8 k € | +7.1% | 45,6 k € | |
| EBITDA | 141,4 k € | +37.6% | 102,8 k € | +11.9% | 91,8 k € | -36.6% | 144,9 k € | +17.5% | 123,3 k € | +35.3% | 91,1 k € | +31.3% | 69,4 k € | +30.7% | 53,1 k € | +48.6% | 35,7 k € | -33.0% | 53,4 k € | +1285.8% | -4,5 k € | -109.0% | 50,2 k € | -12.3% | 57,2 k € | +8.0% | 53,0 k € | +4.9% | 50,5 k € | +197.2% | 17,0 k € | -64.1% | 47,4 k € | +1.3% | 46,7 k € | +7.4% | 43,5 k € | |
| Operating profit | 108,8 k € | +58.6% | 68,6 k € | +18.9% | 57,7 k € | -55.9% | 130,8 k € | +36.0% | 96,2 k € | +55.7% | 61,8 k € | +47.2% | 42,0 k € | +65.8% | 25,3 k € | +203.2% | 8,4 k € | -68.8% | 26,8 k € | +184.7% | -31,6 k € | -304.5% | 15,5 k € | -19.4% | 19,2 k € | -6.4% | 20,5 k € | +84.6% | 11,1 k € | +167.7% | -16,4 k € | -183.1% | 19,8 k € | -3.6% | 20,5 k € | +19.7% | 17,1 k € | |
| Profit/loss | 75,0 k € | +66.5% | 45,1 k € | +19.5% | 37,7 k € | -61.1% | 96,8 k € | +41.3% | 68,5 k € | +58.5% | 43,2 k € | +52.5% | 28,3 k € | +94.2% | 14,6 k € | +899.0% | 1,5 k € | -88.4% | 12,6 k € | -15.1% | 14,9 k € | +244.6% | 4,3 k € | -38.0% | 7,0 k € | +7.0% | 6,5 k € | +320.6% | -2,9 k € | -138.7% | 7,6 k € | +1.3% | 7,5 k € | -31.2% | 10,9 k € | +37.6% | 7,9 k € | |
| Equity | 340,2 k € | -7.6% | 368,0 k € | +5.0% | 350,5 k € | +11.5% | 314,4 k € | +42.5% | 220,7 k € | +43.5% | 153,8 k € | +35.9% | 113,2 k € | +30.9% | 86,4 k € | +20.3% | 71,8 k € | +2.1% | 70,4 k € | +21.8% | 57,8 k € | +34.6% | 42,9 k € | +11.2% | 38,6 k € | +22.0% | 31,6 k € | +25.9% | 25,1 k € | -10.5% | 28,1 k € | +94.0% | 14,5 k € | -29.7% | 20,6 k € | +113.0% | 9,7 k € | |
| Total assets | 419,2 k € | +3.1% | 406,5 k € | +8.2% | 375,8 k € | +8.6% | 346,0 k € | +45.4% | 238,0 k € | +24.2% | 191,6 k € | +9.1% | 175,7 k € | +3.3% | 170,0 k € | -4.1% | 177,2 k € | +19.8% | 147,9 k € | +0.7% | 146,9 k € | +139.4% | 61,4 k € | -28.1% | 85,4 k € | -23.3% | 111,3 k € | -14.5% | 130,2 k € | -27.6% | 179,8 k € | +170.9% | 66,4 k € | -7.8% | 72,0 k € | -16.9% | 86,7 k € | |
| Cash | 149,2 k € | -51.4% | 306,9 k € | +22.2% | 251,2 k € | +32.2% | 190,0 k € | -15.3% | 224,3 k € | +44.1% | 155,6 k € | +40.8% | 110,6 k € | +23.8% | 89,3 k € | +25.2% | 71,3 k € | +10.7% | 64,4 k € | +114.2% | 30,1 k € | +65.5% | 18,2 k € | -5.6% | 19,2 k € | +11.3% | 17,3 k € | +22.8% | 14,1 k € | -51.4% | 29,0 k € | +117.5% | 13,3 k € | -60.4% | 33,7 k € | +44.1% | 23,4 k € | |
| Debts | 75,3 k € | +131.0% | 32,6 k € | +88.6% | 17,3 k € | -19.1% | 21,3 k € | +23.5% | 17,3 k € | -54.3% | 37,8 k € | -39.5% | 62,5 k € | -25.2% | 83,5 k € | -20.7% | 105,4 k € | +36.7% | 77,1 k € | -13.5% | 89,1 k € | +382.7% | 18,5 k € | -60.5% | 46,8 k € | -41.3% | 79,6 k € | -24.2% | 105,1 k € | -23.1% | 136,7 k € | +270.6% | 36,9 k € | +1.2% | 36,4 k € | -41.3% | 62,0 k € | |
Private limited company · Esneux · incorporated on 27/03/1991
Private limited company profitable and well capitalised. Cash position declining (-51.4%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
CABINET MEDICAL DOCTEUR COLLIGNON J.M. is a Private limited company incorporated in 1991. Its main activity is: General medical practice activities. Its registered office is in Esneux.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette